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ABSTRACT
Background: The work incapacity of ankylosing
spondylitis (AS) ranges between 3% and 50% in
Europe. In many countries, work incapacity is difficult
to quantify. The work ability index (WAI) is applied to
measure the work ability in workers, but it is not well
investigated in patients.
Aims: To investigate the work incapacity in terms
of absence days in patients with AS and to
evaluate whether the WAI reflects the absence
from work.
Hypothesis: Absence days can be estimated based on
the WAI and other variables.
Design: Cross-sectional design.
Setting: In a secondary care centre in Switzerland,
the WAI and a questionnaire about work absence
were administered in AS patients prior to
cardiovascular training. The number of absence
days was collected retrospectively. The absence
days were estimated using a two-part regression
model.
Participants: 92 AS patients (58 men (63%)).
Inclusion criteria: AS diagnosis, ability to cycle,
age between 18 and 65 years. Exclusion criteria:
severe heart disease.
Primary and secondary outcome measures:
Absence days.
Results: Of the 92 patients, 14 received a
disability pension and 78 were in the working
process. The median absence days per year of the
78 patients due to AS alone and including other
reasons was 0 days (IQR 0–12.3) and 2.5 days
(IQR 0–19), respectively. The WAI score
(regression coefficient=−4.66 (p<0.001, CI −6.1
to −3.2), ‘getting a disability pension’ (regression
coefficient=−106.8 (p<0.001, 95% CI −141.6 to
−72.0) and other not significant variables
explained 70% of the variance in absence days
(p<0.001), and therefore may estimate the number
of absence days.
Conclusions: Absences in our sample of AS
patients were equal to pan-European countries. In
groups of AS patients, the WAI and other variables
are valid to estimate absence days with the help
of a two-part regression model.
INTRODUCTION
People affected with ankylosing spondylitis
(AS) are impaired in their daily living activ-
ities. This is a problem for both the patients
and the society in terms of the high costs asso-
ciated with the loss of productivity. The mag-
nitude of the disability should be determined
in order to manage AS patients with restric-
tions in the work status effectively. The range
of employment in different countries varies
widely from 34% to 96%, and the incapacity
for work ranges from 3% to 50% depending
on the disease duration. Prevalence of AS
in western Europe is estimated at 0.86%1 2
ARTICLE SUMMARY
Article focus
▪ To measure the incapacity for work in terms of
absence days in patients with ankylosing spon-
dylitis (AS) in Switzerland.
▪ To evaluate whether the work ability index (WAI)
reflects the absence from work.
Key messages
▪ Incapacity for work in a Swiss cohort of AS
patients is similar to the results from other
European studies.
▪ This study shows that the WAI score, together
with specific variables, can be used in AS
patients to calculate their absence days.
▪ Measuring absence days with the help of the
WAI is feasible and cost saving.
Strengths and limitations of this study
▪ The study showed that the WAI is feasible not
only in prevention but also in a clinical setting
for patients with AS.
▪ We took into account that the data are skewed
and checked the goodness of fit of the regres-
sion model by splitting half the group.
▪ Perhaps patients with a high motivation to influ-
ence their health were over-represented in this
study. This could lead to an underestimation of
the absence days.
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to 1.4%.3 Incapacity to work is higher in patients affected
with AS than in the general population. Mean national
sick leave per working individual annually has been mea-
sured to be between 7 and 16 days in the Netherlands,
France and Belgium,4 in comparison to 12–46 days of
sick leave per patient with AS per year5 in the same coun-
tries. In Switzerland, two studies about the work status of
AS patients show different numbers regarding the incap-
acity for work. In one study, 42.5% of patients reported
an occasional incapacity for work due to AS, whereas
13.5% were permanently disabled and received a partial
(10.2%) or full disability pension (3.3%). Days of sick
leave were not reported.6 In an earlier study, the point
estimate of the work ability was measured at 97.3% and
disability at 2.7%.7 This may reﬂect that the evaluation
of the work status is rather complicated because of the
different possible endpoints or deﬁnitions of the work
ability.5 In Switzerland and in most of the other countries,
reliable data about absence days do not exist.8 But
in musculoskeletal rehabilitation, there is a growing
demand for evaluating relevant outcome parameters.
In various studies, information about sickness absence is
gathered from the registered data of companies9 or from
the civil service register.10 But these measurements are not
validated. Nevertheless, there is no direct access to absence
data in many countries, and moreover, to gather such infor-
mation in daily practice is too costly and hardly feasible.
Absence days are a composite of full-time or part-time
work, full or partial work disability, full or partial perform-
ance because of illness. Questionnaire-based evaluations of
absence days are complicated, time-consuming and pos-
sibly not valid. Additionally, it remains unclear whether
absences are due to the disease or due to comorbidities.
An alternative is a comprehensive person-to-person assess-
ment. In Switzerland, the loss of one working day costs
about 600 euro on average,11 and therefore work loss is a
signiﬁcant cost factor in back and musculoskeletal disor-
ders. To our knowledge, only one validated questionnaire
for patients with AS12 exists, however, that takes into
account only to a small part the aforementioned compli-
cated construct of the incapacity for work. The time
span of this questionnaire covers the past 7 days. However,
such a short period may not reﬂect adequately the
course of a disease such as AS. There is another assessment
for working ability, the so-called ‘work ability index’
(WAI),13–15 which is well investigated in the work environ-
ment and in occupational healthcare, where it has been
shown to be predictive15 in terms of future incapacity for
work and disability pension. In a big study with 40 000
nurses, its internal reliability with a Cronbach’s α of 0.72
has been proved to be satisfactory and the concurrent valid-
ity expressed by correlations to other questionnaires
showed consistent and expected correlation coefﬁcients r
of around ±0.5.16 The test–retest reliability revealed accept-
able values with a percentage of observed agreement of
66% between the baseline measurement and the second
measurement which was 4 weeks later. At the group
level, the WAI is stable and did not show any signiﬁcant
difference in the mean between the points of time.17
Recently, the WAI has also been used as an outcome meas-
urement in some intervention and cross-sectional studies
with groups of patients (instead of workers) with different
diseases, for example, musculoskeletal disorders,18 heart
disease, hypertension,19 psychiatric disorders,20 rheuma-
toid arthritis21 or osteoarthritis.22 In all these studies, the
WAI has been shown to be feasible and validly assesses the
ability to work. So far, the WAI has not been applied to
patients with AS.
The aim of this study was to investigate how big the
problem of incapacity to work is in a subgroup of people
with AS in Switzerland. A secondary aim was to develop
a simple method to measure absence days to avoid the
use of complicated and time-consuming assessments or
inaccurate registers. Therefore, the hypothesis was that
the WAI, in combination with other variables, could
potentially serve as a simple instrument for measuring
absence days in AS patients.
STUDY POPULATION AND METHODS
Participants
The participants for this study were all AS patients taking
part in a cardiovascular training study for which the
sample size was computed to detect the effect of the
training. The patients were recruited from the national
Ankylosing Spondylitis Association and from the rheuma-
tology outpatient facilities in our country in 2008/2009.
The last follow-up of the intervention was in 2010.
Inclusion criteria for the cardiovascular training interven-
tion and thus this study were: AS diagnosis following the
modiﬁed New York criteria, the ability to cycle, sufﬁcient
German language ability (for questionnaires), age
between 18 and 65 years, willingness to follow the study
protocol and an informed consent. Chronic heart failure
and functional NYHA Classes III and IV were criteria for
exclusion. The study was approved by the local Ethics
Committee and the patients provided written informed
consent. All patients were randomised to either the car-
diovascular training or an attention control.
Design
We investigated retrospectively the dimension of incap-
acity for work with questions about the work status (QW)
and evaluated the feasibility of an estimation of absence
days by the WAI and other variables. For the latter, a two-
part regression model was built. In the second part of this
model, the absence days which were computed by the
QW were included as dependent variable, and the WAI
with other variables were introduced as independent
variables.
Measurements of the WAI-study
A comprehensive assessment was conducted before the
cardiovascular training. The measurements included the
WAI and additional questions about the work status
(QW) which were gathered retrospectively.
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The WAI is a 13-item questionnaire about (1) the work
conditions, (2) the perception of the present health con-
dition and (3) the perceived prognosis for work. The
WAI is an assessment of the general health, and measures
the work ability in terms of all health conditions. A part
of the WAI deals with a recall period for the last
12 months. One item of the WAI collects the number of
current diseases or comorbidities. The WAI is easy to use
and takes about 10 min to ﬁll in.13 15 The scores range
from 7 to 49 points, with 49 points describing the best
ability to work. The rules to compute the scores are
described in detail.13 The scores of the WAI can be
divided into four categories: 7–27 = poor, 28–36=moder-
ate, 37–43=good, 44–49 = excellent ability to work.
A second questionnaire about the work status (QW)
with the aim to calculate absence days was created with
different substantial questions about the work ability. In
contrast to the brief WAI, the comprehensive QW ought
to reveal more accurate information on the complex
construct of the incapacity for work. We selected the
questions of the QW by means of another study,23
addressing the disability to work, and on the basis of the
clinical experience on determining the work ability. The
items of the QW include working tasks (mental, physical
or mixed), full-time or part-time work, full or partial
work disability during the last year, sick days during the
last year, duration of the work disability, reasons for the
incapacity for work (AS vs other health reasons) and dis-
ability leading to ﬁnancial support.
Procedure
The absence days were computed by means of the QW:
the work disability for the previous year is expressed in
‘days off work due to health reasons’. The QW measures
absence days due to the following reasons: AS alone, not
AS-related health conditions or AS together with other
health problems. Only working days are counted,
whereas weekends and holidays are not included. The
work disability is composed of the number of complete
sick days and of the partial presence at work due to
health reasons. For instance, 30% incapacity for work in
a full-time job during a distinct period is converted into
the corresponding number of sick days. The numbers
are adjusted for part-time work, for example, if someone
is employed for 50%, then the days of sick leave consist
of only half of the absence days of those on full-time
employment. The work disability, days off work and early
retirement due to AS, in contrast to other health pro-
blems, were considered separately from each other as
was also done in a review.5 One could argue that the
WAI contains an item that assesses self-reported sick
leave over the previous 12 months; therefore, it would
not be necessary to measure the absence days with the
more complicated QW. But Radkiewicz and
Widerszal-Bazyl16 pointed out that the aforementioned
item of the WAI should be excluded from the WAI,
because there is no substantial relationship between
this item and the overall score. Furthermore, this item
diminishes the internal validity, and thus the QW was
introduced to measure absence days.
Statistics
The data were checked for normal distribution.
Appropriate parametric and non-parametric statistics,
depending on the distribution, were applied.
Non-parametric statistics were used to compare the distri-
butions for the demographic variables and the absence
days across the groups. The level of signiﬁcance was set at
α = 0.05. With regard to the main aim of the study,
descriptive statistics were used to depict demographic
data, the absence days (on the basis of the QW) and the
WAI score. The WAI score and the absence days in the
QW were correlated to evaluate the relation and the con-
current validity between the two questionnaires.
Pertaining to the second aim of the study, namely to get a
simple way to measure absence days, a two-part regression
model was conducted. If the dependent variable has
many zero-values, like in our study the cases without
absence days, two-part models are suitable to get
unbiased estimators and therefore unbiased prediction
for the values of the dependent variable. First, we
performed a logistic regression analysis to assess the loga-
rithmic odds for the predicting variables which can be
used to compute the probability for a patient to
have absence days. The logistic regression model is:
Logit = b0 + b1x1+b2x2+…+b5x5. The logit of one observa-
tion ‘i’ for the absence days can be transformed in the
logarithmic odds (exp(Logit)), and in the second step,
the probability for absence days is computed by dividing
the ‘odds’ through (odds +1). In the second step of the
two-part model we estimated with a multiple-linear
regression analysis the number of absence days in
patients with absences. By multiplying the probability of
the logistic regression with the result of the linear regres-
sion, an estimation of the absence days is obtained. These
regression models allow the estimation of the absence
days as a constructed value in prospective studies.
The number of absence days calculated by the QW repre-
sents the dependent variable in the multiple-regression
model. Age and gender were assessed as confounding
variables. The statistical software PASW statistics (V.18)
was used for the analysis.
RESULTS
Of the 185 eligible patients, 77 refused to participate
and 16 were excluded due to the exclusion criteria.
Table 1 shows the demographic variables and AS-speciﬁc
functional health indices like the Bath AS Disease
Activity Index (BASDAI; perceived disease activity),24
BASFI (physical function),25 Bath AS Metrology Index
(spinal mobility)26 and Ankylosing Spondylitis Disease
Activity Score(CRP) (calculated by using parameters
from BASDAI and C reactive protein values).27 Further,
table 1 shows the work status and the mental or physical
job demands of the 92 patients in the working age who
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were included. Four of these received a full pension
(3 patients because of AS, 1 because of other reasons)
and 10 a partial disability pension. The remaining
78 individuals (84.7%) were still in the working process
and worked 88.9% of a full-time job per year. There
were 34 (37%) people without any absence days. Table 2
shows the WAI scores and the absence days computed
on the basis of the QW. Where the data are skewed,
median values are presented in table 2. A patient may
have absence days due to (1) AS alone, (2) other health
problems (eg, depression) or (3) both. Therefore, the
median is zero for (1) and (2), but bigger than zero for
(3). There were no missing values in the main variables.
Although the data were skewed, we also calculated the
mean values for absence days, expressed as the percent-
age of the working time per year. This will allow a com-
parison of the absence days to those of other studies.
The 78 patients had a mean of 17.9 absence days
(SD±43.7) due to AS only, which is equivalent to 8.1%
incapacity for work. Owing to other health reasons,
an incapacity for work of 2.5% was calculated. When the
14 patients receiving a disability pension were included
(n=92), the mean absence days due to all reasons was
47.9 days (SD±79.1). These correspond to a disability of
21.6%. The 10 patients with a partial disability pension
were still partially in the working process and had a
mean working time of 41% (SD±31).
Sensitivity analysis: It is unknown whether patients with
a full or a partial disability pension would work 88.9% of
the annual working time, if they would not receive any
disability pension. Hence, the percentage of the disabil-
ity for this group (n=92), presuming that the patients
would work 100% or 80% of a full-time job, was calcu-
lated. Under this presumption, the disability due to all
health problems would be 19.2% and 24%, respectively.
The Spearman correlation between the WAI and the
absence days on the basis of the QW, which expresses
the concurrent validity, was −0.736 (p<0.001) for all of
the 92 patients. The scatter plot revealed an over-
representation of cases without absence days. However,
a range correlation should not be analysed, if there are
tied ranks such as the multiple cases with zero absence
days. Therefore, the correlation was calculated for the
subgroup of AS patients which had at least one absence
day per year due to all health problems (n=58), irre-
spective of getting a disability pension. The correlation
reveals an r=−0.755 with a signiﬁcant p value of
p<0.001 (ﬁgure 1).
Secondary study aim
The results of the logistic regression analysis to estimate
the logarithmic odds for a person with AS to have
Table 2 Absence days (AD) and WAI-scores for the patients in the working age
People with >0
absence days, n=58
(63%) Due to
All patients in the
working age (n=92)
Patients without
disability pension (n=78)
Absence days during the
last year, median (IQR)
24 (6.5–127.7) AS alone 0 (0–37.8) 0 (0–12.3)
Other health
problems
0 (0–2) 0 (0–2)
AS and other
health problems
4.5 (0–61.1) 2.5 (0–19)
WAI, mean (SD) – – 34.18 (9.77) 35.93 (9.29)
Absence days measured by the QW.
AS, ankylosing spondylitis; WAI, work ability index.
Table 1 Baseline variables (n=92)
Overall, n=92
Age in years, mean (SD) 46.34 (11.15)
Gender
Men (%) 58 (63.0)
Women (%) 34 (37.0)
Duration in years since AS diagnosis
Mean (SD) 14.55 (12.74)
BASDAI (0–10), mean (SD) 3.45 (2.0)
BASFI (0–10), mean (SD) 2.4 (2.0)
BASMI (0–10), mean (SD) 2.85 (2.0)
ASDAS(CRP), mean (SD) 6.95 (9.25)
Number of current diseases
AS alone 22
+1–2 45
+>2 25
Education, n (%)
≤12 years 60 (65.2)
>12 years 26 (28.3)
Not known 6 (6.5)
Employment status, n (%)
Paid work 68 (73.9)
Unpaid work 6 (6.5)
Unemployed 4 (4.4)
Partial disability pension 10 (10.9)
Full disability pension 4 (4.3)
Job demands (n=78, no disability pension)
Physical 11%
Mental 41%
Both 48%
AS, ankylosing spondylitis; ASDAS(CRP), Ankylosing Spondylitis
Disease Activity Score (calculated with C reactive protein values);
BASDAI, Bath AS Disease Activity Index; BASFI, The Bath AS
Functional Index; BASMI, Bath AS Metrology Index.
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absence days are shown in table 3. The variables ‘age’
and ‘WAI’ were found to be signiﬁcant predictors in this
multiple-logistic regression model. The assumption of
linearity of the logits has been met and the residual
statistics showed acceptable values. A multiple-linear
regression analysis with the QW as a dependent variable
was performed. All signiﬁcant baseline variables, namely
the WAI score, the ‘number of additional co-morbidities’
that were collected by the WAI (split into values up to
2/>2), age and disability pension (yes/no) as well as
gender, were included in the model. The multiple-
regression analysis revealed that 70% of the variance in
the dependent variable absence days (measured by
the complex QW) can be explained by the independent
variables of age, gender, WAI, the number of diagnoses
and a disability pension (table 3). However, only
WAI and ‘getting a disability pension’ signiﬁcantly con-
tributed to the model. Thus, the absence days of an AS
patient can be estimated by multiple regression with
the unstandardised regression coefﬁcients: y=b1*x1
+b2*x2+…+bn*xn+a, where y is the estimated value of
the absence days, n is the number of independent
variables, x1 to xn are the independent variables (age,
gender, WAI, the number of diagnoses and getting a dis-
ability pension), and a is a constant (table 3). Owing to
the skewed distribution of the absence days and the
WAI, we veriﬁed our presented regression model by split-
ting the sample into two halves. We estimated each with
the shown regression model. We then correlated the esti-
mates and the true values of each group. The result of
this was squared and compared with the R2 of the same
group (results not shown). The squared correlation and
the R2 should be similar in order to conﬁrm that the
regression model is capable of predicting the absence
days of another sample quite accurately (eg, the other
half of the group). The differences were 0.18 for the
ﬁrst half and 0.05 for the second half, indicating a good
ﬁt of the model.
DISCUSSION
Key results
Individuals without a disability pension had an 8.1%
incapacity for work, if it was solely due to AS. The
absence days increased by 2.5% when AS patients, who
have had incapacity for work due to other health
reasons, were included. The percentage of absences due
to AS and other health reasons, including the indivi-
duals receiving a disability pension, was 21% as evalu-
ated by the QW. Multiple-regression analysis explained
70% of the variance of the absence days. The two
variables ‘WAI’ and ‘disability pension’ made a signiﬁ-
cant contribution to this model. Thus, the WAI, in com-
bination with other variables, can serve as a simple
instrument for measuring absence days in the various
groups of AS patients.
Table 3 Two-part model: multiple logistic and multiple-linear regression analysis
Model
Independent
variables
B
coefficients
Standardised
regression
coefficients (β)
Significant
p value
95% CI for B
lower/upper
Multiple logistic regression
Predicted variable:
absence days
Constant 11.039 0.000 6.14 15.93
Age −0.065 0.013 −0.116 −0.014
WAI −0.203 0.000 −0.293 −0.113
Multiple linear regression
Predicted variable: number
of absence days
Constant 427.2* – 0.000 317.32 537.08
Disability pension† −106.81* −0.52 0.000 −141.60 −72.02
WAI −4.66* −0.51 0.000 −6.13 −3.18
Age −0.498* −0.07 0.429 −1.75 0.76
Gender −10.71* −0.06 0.414 −36.82 15.40
N° of diagnoses‡ 10.24* 0.06 0.461 −17.45 37.93
The logistic regression has a Nagelkerke R=0.458, the Hosmer and Lemeshow test was not significant (p=0.09), the Omnibus test was very
small (p=0.000).
For the multiple regression, the R2 was 0.724, R2 adjusted 0.7, the model is significant with p<0.001.
*Unstandardised regression coefficients (B).
†Disability pension (yes/no).
‡Number of diagnoses (up to 2/>2).
Figure 1 Scatterplot of the work ability index and absence
days for the subgroup with absence days (n=58).
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Discussing important differences to other studies
The results regarding the absences of a group of AS
patients who underwent cardiovascular training are com-
parable to the ﬁndings of another Swiss cohort.6 But the
number of absence days in our study is slightly lower
than in the review by Boonen et al.5 Higher rates of dis-
ability pension are found in other studies.28–31 The dif-
ferences in the ability to work in different studies are
dependent on several factors such as disease duration
and activity, the perceived self-efﬁcacy to perform a job,
the general health condition and the kind of job (phys-
ical/mental demands).32 However, inﬂuences from dif-
ferent structures of the social insurance system, the job
market situation and cultural differences in absence
behaviour may also be relevant. This has also been
observed in other musculoskeletal disorders.33
Our study showed much higher incapacity for work
measured in absence days than in another Swiss study.7
However, in this other study the working ability of 97.3%
was a point measurement, and the number of patients
only working part-time due to their health condition
had not been identiﬁed. These distinctions in the
methods and the low return rate of questionnaires in
this other study could explain the difference in
the results of these studies. The correlation coefﬁcient
of r=−0.755 reveals a good correlation between the WAI
and the QW. This supports the concurrent validity of the
QW. The negative relationship means that having a low
score in the WAI leads to more absence days.
Implications of this study
The WAI reﬂected the absence days in a group of AS
patients with the help of a two-part regression model. In
the future, absence days may be estimated by multiplying
the probability of the logistic regression with the results
of the linear regression. This may be useful for some
aspects of economic evaluations to quantify the product-
ivity loss.34 Age and gender did not confound the results.
Usually, absence days are very time-consuming and difﬁ-
cult to measure because of part-time work, partial incap-
acity for work, partial or full invalidity pension and the
potential incapability of the patients to recall all the
subtle differences in their absences. Therefore, the WAI
offers some advantages in contrast to questionnaires with
a huge set of questions: it takes only 10 min to be com-
pleted; it reﬂects the subjective view of the patients and
the scoring is clearly understandable.
Strengths of this study
The study showed that the use of the WAI is feasible not
only in a prevention setting such as occupational health-
care but also in a clinical setting for patients with AS. We
took into account that the data are skewed and checked
the goodness of ﬁt of the regression model by splitting
the group into two halves, estimating the values of the
other half and by correlating the true values with the
estimated values. The procedure conﬁrmed the stability
of the regression model.
Weaknesses of the study
The absence days were gathered retrospectively. The preci-
sion of people’s memory to report the number of absence
days of the previous year is questionable,35 and therefore
the absence days computed by the QW may not be accur-
ate. Severens et al postulated that a 64% agreement
between self-reported and register gathered absence days
results, if a 3 day discrepancy in absence days is regarded as
acceptable. The results of this study are not generalisable
for other subjects than people with AS. Perhaps patients
with a high motivation to inﬂuence their health were over-
represented in this study, since they were readily willing to
undergo cardiovascular training. Such patients may also
have been more willing to maintain their ability to work.
This could lead to an underestimation of the absence days.
Since a questionnaire encompassing the complicated
nature of the construct of the incapacity for work does
only exist to report absence days over a very short time
span, we made use of the new not validated QW. The
substantial correlation between the WAI and the QW
implicates an acceptable concurrent validity. The sample
size is not very big to conduct a multiple-regression ana-
lysis. However, we had 11 patients per variable and this
lies above the recommended number of patients (5–10
times the number of included variables).
In summary, statistical models using the WAI for esti-
mating absence days offer an innovative and time-saving
approach for studies where incapacity for work has to be
measured.
CONCLUSIONS
Incapacity for work in a sample of AS patients was equal
to that in pan-European countries. The WAI was feasible
for use in AS patients. It validly assesses incapacity for
work evaluating groups of participants suffering from
AS. In the future, absence days may be calculated by
computing the absence days through a regression ana-
lysis including the WAI score as a variable. Further
research may evaluate whether these results are replic-
able in patients with other health conditions than AS.
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